ValorQ4, 24Q1, 25Q2, 25Q3, 25TTMGastos comerciales, generales y administrativos2.72 B2.81 B2.96 B2.96 B11.45 BInvestigación y desarrollo684 M726 M754 M722 M2.89 BBeneficio operativo1.44 B1.45 B1.69 B1.46 B6.03 BTotal de ingresos no operativos6 M-57 M92 M121 M162 MGastos por intereses, netos de intereses capitalizados394 M393 M403 M404 M1.59 BIngresos no operativos, una vez deducidos los gastos por intereses-388 M-483 M-403 M-404 M-1.68 BIngresos/gastos extraordinarios033 M92 M121 M246 MBeneficio antes de impuestos1.26 B1.3 B1.6 B1.4 B5.56 BParticipación en los beneficios—————Impuestos198 M255 M215 M254 M922 MParticipación minoritaria5 M7 M7 M6 M25 MOtros ingresos/gastos después de impuestos-296 M-159 M-8 M-113 M-576 MBeneficio neto antes de actividades interrumpidas1.06 B1.04 B1.37 B1.14 B4.61 BOperaciones suspendidas—————Beneficio neto1.06 B1.04 B1.37 B1.14 B4.61 BAjuste por dilución—————Dividendos de las acciones preferentes—————Beneficio neto diluido atribuible a los accionistas1.06 B1.04 B1.37 B1.14 B4.61 BBeneficio básico por acción0.820.811.070.893.59Beneficio por acción diluido0.810.811.070.893.58Número medio de acciones ordinarias1.29 B1.28 B1.28 B1.28 B5.13 BAcciones diluidas1.29 B1.29 B1.29 B1.29 B5.15 BEBITDA1.29 B2.14 B2.28 B2.04 B7.75 BEBIT452 M1.39 B1.53 B1.29 B4.67 BCosto de los ingresos3.15 B3 B3.06 B3.26 B12.47 BOtros costes de producción—————Amortización y depreciación (flujo de caja)840 M748 M745 M749 M3.08 B
Medtronic plc
Medtronic plc is an American-Irish medical device company. The company's legal and executive headquarters are in Ireland, while its operational headquarters are in Minneapolis, Minnesota. Medtronic rebased to Ireland following its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United States, it operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. It is one of the biggest medical tech companies in the world and is currently the largest medical device company in the world by revenue.
The company has developed several world-first technologies since its inception, including wearable and implantable pacemakers, the implantable cardioverter-defibrillator, and remote monitoring systems. They also created miniaturized devices like the world's smallest pacemaker and spinal cord stimulator.